Your browser is no longer supported. Please, upgrade your browser.
Settings
SCLN SciClone Pharmaceuticals, Inc. daily Stock Chart
SCLN [NASD]
SciClone Pharmaceuticals, Inc.
Index- P/E21.64 EPS (ttm)0.39 Insider Own0.60% Shs Outstand49.37M Perf Week4.07%
Market Cap416.68M Forward P/E- EPS next Y- Insider Trans-17.35% Shs Float43.40M Perf Month6.97%
Income20.40M PEG1.53 EPS next Q- Inst Own76.10% Short Float7.60% Perf Quarter-12.63%
Sales155.80M P/S2.67 EPS this Y140.00% Inst Trans-1.74% Short Ratio10.48 Perf Half Y2.30%
Book/sh3.33 P/B2.53 EPS next Y- ROA10.80% Target Price10.00 Perf Year9.75%
Cash/sh2.01 P/C4.20 EPS next 5Y14.10% ROE12.70% 52W Range6.47 - 11.71 Perf YTD-8.26%
Dividend- P/FCF13.94 EPS past 5Y13.90% ROI16.00% 52W High-27.92% Beta1.67
Dividend %- Quick Ratio3.90 Sales past 5Y13.20% Gross Margin84.20% 52W Low30.45% ATR0.47
Employees570 Current Ratio4.20 Sales Q/Q25.10% Oper. Margin13.40% RSI (14)54.33 Volatility5.88% 5.80%
OptionableYes Debt/Eq0.00 EPS Q/Q53.30% Profit Margin13.20% Rel Volume0.97 Prev Close8.44
ShortableYes LT Debt/Eq0.00 EarningsMar 09 AMC Payout0.00% Avg Volume314.79K Price8.44
Recom4.00 SMA204.94% SMA50-1.02% SMA200-1.50% Volume0 Change0.00%
Nov-14-14Downgrade BWS Financial Buy → Hold $8.25 → $8
Nov-12-13Reiterated Aegis Capital Buy $9 → $8
Jul-16-13Upgrade Aegis Capital Hold → Buy $9
Sep-18-12Upgrade BWS Financial Hold → Buy $8.25
Aug-10-10Downgrade BWS Financial Buy → Hold $7.25 → $4.50
Apr-09-10Upgrade BWS Financial Hold → Buy $7.25
Jul-08-09Downgrade BWS Financial Buy → Hold $3.25
Jun-03-09Initiated ThinkEquity Buy $5
May-21-09Initiated Rodman & Renshaw Mkt Outperform $5
Sep-05-08Initiated Susquehanna Financial Neutral
Feb-08-16 08:05AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : February 8, 2016
Feb-04-16 06:29PM  [$$] SciClone Launches Strategic Review at The Wall Street Journal
05:09PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
05:01PM  SciClone Announces Final Resolution With The Securities And Exchange Commission And The Department Of Justice PR Newswire
Jan-27-16 06:00AM  SciClone To Present At BIO CEO & Investor Conference On February 9, 2016 PR Newswire
Jan-26-16 04:32PM  Soligenix Provides 2016 Business Outlook Reviews 2015 Achievements and 2016 Milestones at noodls
Jan-11-16 09:02AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
06:00AM  SciClone Announces Preliminary 2015 Revenue PR Newswire
Jan-05-16 08:46AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : January 5, 2016
Dec-21-15 12:51PM  SciClone Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers
06:00AM  SciClone To Pursue Development Of SGX942 In China Following Soligenix' Report Of Positive Phase 2 Preliminary Results In Oral Mucositis PR Newswire
Dec-18-15 08:00AM  Healthcare Sector Equities under the Scanner -- Zogenix, Amarin, SciClone Pharma, and PetMed Express Accesswire
Dec-08-15 01:17PM  SCICLONE PHARMACEUTICALS INC Financials
Nov-27-15 09:17AM  Hedge Funds Arent Crazy About SciClone Pharmaceuticals, Inc. (SCLN) Anymore at Insider Monkey
Nov-24-15 04:18PM  Is Tristate Capital Holdings Inc (TSC) A Good Stock To Buy? at Insider Monkey
Nov-20-15 07:45AM  What's Moving the Markets - Research on Aegean Marine, REX American Resources, SciClone and Blue Nile Accesswire
Nov-17-15 11:57AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
06:00AM  SciClone To Present At 27th Annual Piper Jaffray Healthcare Conference On December 2, 2015 PR Newswire
Nov-14-15 09:20AM  7 BioHealth Movers That Cannot Be Ignored at 24/7 Wall St.
Nov-12-15 08:05AM  Moving Ahead of Averages, Technical Review - Research on Aegean Marine Petroleum Network, SciClone Pharmaceuticals, Noodles & Co, and Nuveen Floating Rate Income Opportunity Fund Accesswire -11.60%
Nov-11-15 04:26PM  SciClone Pharmaceuticals, Inc.: Leads amongst peers with strong fundamentals
01:00PM  Theravance Biopharma Posts Wider-than-Expected Q3 Loss
12:17PM  Story Stocks from Briefing.com Briefing.com
Nov-10-15 03:18PM  4 Stocks That Moved Massively After Earnings at 24/7 Wall St. +20.90%
02:16PM  Why SciClone Pharmaceuticals Is Soaring Today at Motley Fool
11:59AM  Here Is Why These Four Stocks Stand Out from the Crowd on Tuesday at Insider Monkey
03:53AM  Edited Transcript of SCLN earnings conference call or presentation 9-Nov-15 9:30pm GMT
01:16AM  Trending Now: SCLN
Nov-09-15 06:53PM  SciClone posts 3Q profit
04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
04:11PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  SciClone Reports Third Quarter 2015 Financial Results PR Newswire
07:07AM  Q3 2015 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
Nov-05-15 08:10AM  Tracking the Market Movement - Research on SciClone Pharmaceuticals, Blue Nile, Noodles & Co. and PIMCO Strategic Income Fund Accesswire
Nov-03-15 06:00AM  SciClone To Present At Boston Biotech NY/NJ CEO Conference On November 12th PR Newswire
Oct-28-15 01:54PM  SciClone Pharmaceuticals, Inc. Value Analysis (NASDAQ:SCLN) : October 28, 2015
Oct-26-15 06:00AM  SciClone Pharmaceuticals To Report Financial Results For The Third Quarter 2015 On November 9th PR Newswire
Oct-21-15 09:03AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : October 21, 2015
Sep-30-15 06:00AM  SciClone To Present At 2015 Aegis Capital Growth Conference On October 9th PR Newswire
Sep-24-15 09:00AM  Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00 Marketwired
Aug-27-15 06:00AM  SciClone To Present At Two Investor Conferences On September 10, 2015 PR Newswire
Aug-12-15 08:12PM  10-Q for SciClone Pharmaceuticals, Inc. at Company Spotlight
Aug-11-15 11:50AM  Theravance Biopharma Posts Narrower Q2 Loss, View Revised - Analyst Blog -13.04%
Aug-10-15 07:30PM  Edited Transcript of SCLN earnings conference call or presentation 10-Aug-15 8:30pm GMT
05:19PM  SciClone reports 2Q loss
04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
04:04PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:01PM  SciClone Reports Second Quarter 2015 Financial Results PR Newswire
07:07AM  Q2 2015 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
Jul-23-15 09:10AM  Cancer Prevention Pharmaceuticals, Inc. Announces Appointment of Jon S. Saxe to its Board of Directors PR Newswire
06:00AM  SciClone Pharmaceuticals To Report Financial Results For The Second Quarter 2015 On August 10th PR Newswire
Jul-20-15 08:32AM  3 Reasons SciClone Pharmaceuticals (SCLN) is a Great Value Stock - Tale of the Tape
Jul-01-15 05:43PM  SciClone Shoots Out of Base, Phibro Turns Tail at Investor's Business Daily +14.46%
03:43PM  Should You Buy Surging SciClone Pharmaceuticals (SCLN), Up By 14.66% Today? at Insider Monkey
Jun-27-15 03:02AM  Edited Transcript of SCLN presentation 3-Jun-15 2:30pm GMT
Jun-20-15 03:45AM  Edited Transcript of SCLN earnings conference call or presentation 11-May-15 8:30pm GMT
Jun-17-15 04:40PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
Jun-16-15 09:08AM  Buy These 6 Risky Pharmaceutical Stocks for Big Upside Potential at TheStreet
May-27-15 11:54AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:05AM  Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China Marketwired
08:05AM  SciClone Pharmaceuticals and Theravance Biopharma Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China Marketwired
May-26-15 06:00AM  SciClone to Present at Jefferies 2015 Global Healthcare Conference on June 3, 2015 Marketwired
May-21-15 09:00AM  Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00 Marketwired -5.39%
May-13-15 08:11PM  10-Q for SciClone Pharmaceuticals, Inc. at Company Spotlight
May-11-15 05:24PM  SciClone posts 1Q profit
04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
04:07PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:07AM  Q1 2015 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
May-05-15 08:12PM  10-K for SciClone Pharmaceuticals, Inc. at Company Spotlight
Apr-30-15 06:32AM  SciClone Pharmaceuticals to Report Financial Results for the First Quarter 2015 on May 11th at noodls
06:00AM  SciClone Pharmaceuticals to Report Financial Results for the First Quarter 2015 on May 11th Marketwired
Apr-06-15 04:09PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
06:03AM  SciClone to Present at Needham Healthcare Conference on April 14, 2015 at noodls
06:00AM  SciClone to Present at Needham Healthcare Conference on April 14, 2015 Marketwired
Mar-19-15 06:04AM  SciClone to Present at Investor and Partnering Conferences in China at noodls
06:00AM  SciClone to Present at Investor and Partnering Conferences in China Marketwired
Mar-12-15 05:27PM  SCICLONE PHARMACEUTICALS INC Files SEC form 10-K, Annual Report +9.80%
09:20AM  SciClone (SCLN) Beats on Q4 Earnings, Gives 2015 Outlook - Analyst Blog
Mar-11-15 05:07PM  SciClone posts 4Q profit
04:50PM  SciClone Reports 2014 Financial Results and 2015 Outlook at noodls
04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
04:08PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  SciClone Reports 2014 Financial Results and 2015 Outlook Marketwired
07:07AM  Q4 2014 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
Feb-25-15 06:15AM  SciClone Pharmaceuticals to Report Financial Results for the Fourth Quarter and Full Year 2014 on March 11th at noodls
06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Fourth Quarter and Full Year 2014 on March 11th Marketwired
Jan-28-15 04:05PM  Correction: SciClone to Present at BIO CEO & Investor Conference on February 9, 2015 at 11 am ET Marketwired
06:00AM  SciClone to Present at BIO CEO & Investor Conference on February 9, 2015 Marketwired
Jan-06-15 12:22PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
06:00AM  SciClone Provides 2014 Financial Update and 2015 Revenue Guidance Marketwired
Dec-18-14 12:56PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +5.10%
Nov-14-14 12:19PM  SciClone Pharma downgraded by BWS Financial Briefing.com
Nov-12-14 07:09PM  10-Q for SciClone Pharmaceuticals, Inc. Company Spotlight +5.22%
Nov-10-14 04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN +5.06%
04:08PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:05PM  SciClone Reports Financial Results for the Third Quarter 2014 Marketwired
07:07AM  Q3 2014 SciClone Pharmaceuticals Inc Earnings Release - After Market Close CCBN
Nov-06-14 06:00AM  SciClone to Present at Jefferies Global Healthcare Conference on November 19th Marketwired
Nov-03-14 12:34PM  Story Stocks from Briefing.com Briefing.com
Oct-30-14 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Third Quarter 2014 on November 10th Marketwired
SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, provides therapies for oncology, infectious diseases, and cardiovascular disorders in the People's Republic of China, the United States, and Hong Kong. Its lead product is ZADAXIN, which is used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as a vaccine adjuvant, and as a chemotherapy adjuvant for cancer patients with weakened immune systems. The company also focuses on development ZADAXIN for the treatment of sepsis. ZADAXIN has approval in approximately 30 countries, which include China, the Pacific Rim, Latin America, Eastern Europe, and the Middle East regions. The company markets and sells ZADAXIN through distribution arrangements, local importers, and distributors. In addition, it markets approximately seven partnered products in China, including Aggrastat, an interventional cardiology product. Further, the company holds license, promotion, distribution, or marketing agreements with various parties for products, including DC Bead, Holoxan, Mesna, Endoxan, Methotrexate, Estracyt, Farlutal, Neucardin, ProFlow, Angiomax, and Cleviprex. SciClone Pharmaceuticals, Inc. also has an agreement with MEDA Pharma GmbH & Co. KG for the development of Tramadol. The company was founded in 1989 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blobel FriedhelmPresident & CEOJan 04Option Exercise2.49200498204,452Jan 06 01:33 PM
SAXE JON SDirectorJan 04Option Exercise2.4630,00073,800105,000Jan 06 01:40 PM
Blobel FriedhelmPresident & CEOJan 04Sale9.012001,802204,252Jan 06 01:33 PM
Blobel FriedhelmPresident & CEODec 28Option Exercise2.4910,00024,900214,252Dec 29 12:19 PM
Blobel FriedhelmPresident & CEODec 28Sale9.1710,00091,697204,252Dec 29 12:19 PM
Blobel FriedhelmPresident & CEODec 17Option Exercise2.499,40023,406211,673Dec 18 05:40 PM
Blobel FriedhelmPresident & CEODec 17Sale9.009,40084,600202,273Dec 18 05:40 PM
Blobel FriedhelmPresident & CEODec 11Option Exercise2.496001,494202,873Dec 14 05:39 PM
Blobel FriedhelmPresident & CEODec 11Sale9.006005,402202,273Dec 14 05:39 PM
Blobel FriedhelmPresident & CEODec 04Option Exercise2.4910,00024,900212,273Dec 07 11:12 AM
Blobel FriedhelmPresident & CEODec 04Sale9.2210,00092,211202,273Dec 07 11:12 AM
Xie LanVP Finance, China CFODec 03Option Exercise4.9114,16669,4938,125Dec 07 11:57 AM
Xie LanVP Finance, China CFODec 03Sale9.5014,166134,5770Dec 07 11:57 AM
Blobel FriedhelmPresident & CEONov 27Option Exercise2.4910,00024,900212,273Nov 30 04:30 PM
Blobel FriedhelmPresident & CEONov 27Sale9.2410,00092,419202,273Nov 30 04:30 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceNov 10Sale9.517,80374,2070Nov 10 05:01 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceAug 13Option Exercise0.0012,500012,500Aug 17 12:36 PM
Blobel FriedhelmPresident & CEOJul 31Option Exercise2.4910,00024,900212,273Aug 03 04:33 PM
Blobel FriedhelmPresident & CEOJul 31Sale9.1510,00091,515202,273Aug 03 04:33 PM
Blobel FriedhelmPresident & CEOJul 24Option Exercise2.4910,00024,900212,273Jul 27 06:10 PM
Blobel FriedhelmPresident & CEOJul 24Sale9.6810,00096,755202,273Jul 27 06:10 PM
Blobel FriedhelmPresident & CEOJul 17Option Exercise2.4910,00024,900212,273Jul 20 05:04 PM
Blobel FriedhelmPresident & CEOJul 17Sale9.7210,00097,162202,273Jul 20 05:04 PM
Blobel FriedhelmPresident & CEOJul 10Option Exercise2.4910,00024,900212,273Jul 14 10:52 AM
Blobel FriedhelmPresident & CEOJul 10Sale9.2110,00092,143202,273Jul 14 10:52 AM
Blobel FriedhelmPresident & CEOJul 06Option Exercise2.4920,00049,800222,273Jul 07 10:51 AM
Blobel FriedhelmPresident & CEOJul 06Sale10.8020,000215,912202,273Jul 07 10:51 AM
Blobel FriedhelmPresident & CEOJun 26Option Exercise2.4910,00024,900212,273Jun 29 01:49 PM
Blobel FriedhelmPresident & CEOJun 26Sale9.2910,00092,910202,273Jun 29 01:49 PM
Blobel FriedhelmPresident & CEOJun 19Option Exercise2.4910,00024,900212,273Jun 22 01:02 PM
Blobel FriedhelmPresident & CEOJun 19Sale9.4210,00094,153202,273Jun 22 01:02 PM
Blobel FriedhelmPresident & CEOJun 12Option Exercise2.4910,00024,900212,273Jun 15 04:10 PM
Meng ChuncaiGen. Counsel & VP ComplianceJun 12Option Exercise4.523,00713,5923,007Jun 15 04:13 PM
Meng ChuncaiGen. Counsel & VP ComplianceJun 12Sale9.233,00727,7550Jun 15 04:13 PM
Blobel FriedhelmPresident & CEOJun 12Sale9.1310,00091,304202,273Jun 15 04:10 PM
Zhao HongCEO, China OperationsJun 08Option Exercise4.5210,00045,20010,000Jun 09 11:15 AM
Zhao HongCEO, China OperationsJun 08Sale9.2310,00092,3380Jun 09 11:15 AM
Blobel FriedhelmPresident & CEOJun 05Option Exercise2.4910,00024,900212,273Jun 08 01:34 PM
Blobel FriedhelmPresident & CEOJun 05Sale9.0710,00090,705202,273Jun 08 01:34 PM
Hawkins Richard JDirectorJun 01Option Exercise3.274,57014,9444,570Jun 02 06:10 PM
Hawkins Richard JDirectorJun 01Sale9.274,57042,3710Jun 02 06:10 PM
Blobel FriedhelmPresident & CEOMay 29Option Exercise2.4910,00024,900211,273Jun 01 01:32 PM
Hawkins Richard JDirectorMay 29Option Exercise3.2710,43034,10610,430Jun 01 01:33 PM
Hawkins Richard JDirectorMay 29Sale9.3210,43097,1820Jun 01 01:33 PM
Blobel FriedhelmPresident & CEOMay 29Sale9.3810,00093,821201,273Jun 01 01:32 PM
Hawkins Richard JDirectorMay 26Sale9.4411,982113,1450May 26 05:38 PM
Blobel FriedhelmPresident & CEOMay 22Option Exercise2.4910,00024,900211,273May 26 02:21 PM
Blobel FriedhelmPresident & CEOMay 22Sale9.4010,00094,014201,273May 26 02:21 PM
Hawkins Richard JDirectorMay 21Sale9.713,70035,91411,982May 26 11:45 AM
Meng ChuncaiGen. Counsel & VP ComplianceMay 18Option Exercise4.5223,660106,94323,660May 19 01:33 PM
Meng ChuncaiGen. Counsel & VP ComplianceMay 18Sale9.5623,660226,0710May 19 01:33 PM
Xie LanVP Finance, China CFOMay 15Option Exercise4.8326,668128,73312,188May 18 07:54 PM
Blobel FriedhelmPresident & CEOMay 15Option Exercise2.4910,00024,900222,973May 18 07:34 PM
Xie LanVP Finance, China CFOMay 15Sale9.2026,668245,3460May 18 07:54 PM
Blobel FriedhelmPresident & CEOMay 14Option Exercise0.0080,5170212,973May 18 07:34 PM
Zhao HongCEO, China OperationsMay 14Option Exercise0.0012,500012,500May 18 08:00 PM
Zhao HongCEO, China OperationsMay 14Sale9.0712,500113,3750May 18 08:00 PM
Hawkins Richard JDirectorMay 14Sale9.1618,727171,57115,682May 18 07:41 PM
Blobel FriedhelmPresident & CEOApr 24Option Exercise2.4910,00024,900177,652Apr 24 07:02 PM
Blobel FriedhelmPresident & CEOApr 24Sale9.0710,00090,667167,652Apr 24 07:02 PM
Blobel FriedhelmPresident & CEOApr 10Option Exercise2.4910,00024,900177,652Apr 13 03:57 PM
Blobel FriedhelmPresident & CEOApr 10Sale9.1010,00091,006167,652Apr 13 03:57 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceMar 12Sale9.077,80370,7730Mar 16 11:26 AM
SAXE JON SDirectorMar 04Option Exercise3.2730,00098,10075,000Mar 05 02:34 PM